The market for surgical closure and securement has entered a phase in which major driving forces are the introduction of new procedures and techniques by the surgical profession, the development by the medical device industry of new wound closure devices and biomaterials, and the growing willingness of surgical specialists to use these devices in appropriate [...]
In spite of arguments contesting whether bare metal or drug-eluting stents perform better, drug-eluting stents are here to stay and are still used in the majority of stent implantations. In fact, a plethora of studies have shown that DES can improve mortality rates and reduce the need for target vessel revascularization (TVR) compared with BMS. [...]
Products used in surgical closure and securement include multiple types, from sutures, staples and tapes to fibrin sealants, fibrin glues, high-strength glues (e.g., cyanoacrylates, others), hemostasis and others. Clinicians managing surgical or traumatic wounds choose the appropriate product or product combination based on wound type, location, patient status and other considerations. From the manufacturer’s standpoint, [...]
In cardiovascular and spine surgery, multi-billion dollar markets were created from entirely new procedures between 1980 and 2000, with subsequent segmentation in later years particularly as new minimally invasive procedures were developed towards the end of the 20th century. In the cardiovascular arena, the development of new procedures for angioplasty and bypasses in the late [...]
Below are recent global medical technology market reports from MedMarket Diligence: “Worldwide Drug-Eluting, Bare and Other Coronary Stents Market, 2008-2017.”. See details. “Worldwide Market for Surgical Sealants, Glues, Wound Closure, 2009-2013.” See details. “Ablation Technologies Worldwide Market, 2008-2017:Products, Technologies, Markets, Companies and Opportunities.” See details. bookmark to
Cardiovascular disease is the leading cause of mortality in the United States with heart disease affecting 13 million people. Approximately 10% of these patients are estimated to be candidates who, as part of their primary treatment are also candidates for the most advanced technologies in surgical securement. Current uses of surgical securement technologies in [...]
Putting the market in focus, particularly the global opportunities for wound closure and its larger role in wound management demands addressing the applications for surgical sealants, glues, hemostasis and anti-adhesion. Given the opportunities that exist globally, few competitors (if any) can seriously focus on, for example, the U.S. or Europe only, since competition in this [...]
The market for "surgical securement" products is subdivided into the following product categories: sutures, staples and other mechanical closure devices tapes hemostats fibrin and other sealants high-strength medical adhesives post-surgical adhesion prevention. The total securement market is forecast over the next four years at a compound annual growth rate of 8.4%. Definition of Surgical Closure and [...]
Surgical wounds are projected to increase in number at an annual rate of 3%, but overall the severity and size of surgical wounds will continue to decrease over the next five years as a result of the continuing trend toward minimally invasive surgery. Surgical procedures generate a large number of uncomplicated acute wounds with uneventful [...]
Sutures and staples are at an aging stage in their product life cycle; there are numerous predicate devices, and the materials are well established and cover most of the spectrum of clinical need for suturing. However, a great number of procedure-enhancing devices have been developed in the last seven years, particularly as minimally invasive surgery [...]
Contact:
